Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2): an international randomised, placebo-controlled, phase 3 superiority trial

Background Tranexamic acid (TXA) reduces death due to bleeding after trauma and post-partum haemorrhage. The aim was to assess if tranexamic acid reduces haematoma expansion and improves outcome in adults with stroke due to intracerebral 6 haemorrhage (ICH). Methods We undertook an international...

Full description

Bibliographic Details
Main Authors: Sprigg, Nikola, Flaherty, Katie, Appleton, Jason P., Al-Shahi Salman, Rustam, Bereczki, Daniel, Beridze, M., Christensen, Hanne, Ciccone, Alfonso, Collins, Ronan, Czlonkowska, Anna, Dineen, Robert A., Duley, Lelia, Egea-Guerrero, Juan Jose, England, Timothy J., Krishnan, Kailash, Laska, Ann Charlotte, Law, Zhe Kang, Ozturk, Serefnur, Pocock, Stuart J., Roberts, Ian, Robinson, Thompson G., Roffe, Christine, Seiffge, David, Scutt, Polly, Thanabalan, Jegan, Werring, David, Whynes, David, Bath, Philip M.
Format: Article
Published: Elsevier 2018
Subjects:
Intracerebral haemorrhage; tranexamic acid; randomised controlled trial
Online Access:https://eprints.nottingham.ac.uk/51667/

Internet

https://eprints.nottingham.ac.uk/51667/

Similar Items